Skip to main content
Signal8

Strategic Partners A/S (OZYMF)

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.

Sector: Biotechnology

Industry: Biotechnology

Strategic Partners A/S logo

Strategic Partners A/S

OTC:OZYMFHealthcare
Mkt Cap-
EV-
Float40K
O/S54K
Inst Own-
Net Cash/Sh-
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 39.57K · FMP free float

Not published: no settled short interest on record.
Not stated: no basis-consistent volume to divide the settled position by.
Borrow (IBKR)

The cost to borrow OZYMF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for OZYMF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually